Market for Deep Brain Stimulation Devices for Parkinson’s Disease to be Worth USD 9.4 Billion by 2019: Transparency Market Research

Albany, New York (PRWEB) July 03, 2014

According to a latest market research report published by Transparency Market Research, the global market for Deep Brain Stimulation Devices for Parkinson’s Disease is projected to be worth USD 9.4 billion by the end of 2019. The next few years are poised to be one of the most promising growth phases for this market considering it was valued at USD 4.5 billion as of 2012.

The insightful market research report is based on high-quality primary and secondary research with data collated via in-depth interviews and discussions with opinion leaders, besides an extensive study of market players’ product and corporate literature, annual reports and more.

The report provides users with an overview of the causative factors that will directly influence the demand for deep brain stimulation devices for treating persons suffering from Parkinson’s disease. It speaks about various neurological disorders such as Alzheimer’s disease, trauma, Parkinsonism, ischemic stroke and other similar disorders that are likely have a direct impact on the need for DBS devices. Parkinson’s disease is characterized by symptoms such as postural instability, akinesia, and bradykinesia among others. In the recent past, incidences of Parkinson’s disease have increased multifold, making it the second-most common progressive and chronic neurodegenerative disorder.

The report suggests that some of the key factors that have caused an increase in the demand for DBS devices are a preference for surgical techniques that are minimally invasive-especially among the geriatric population that is more prone to this disorder. In fact, there is a growing inclination among medical practitioners as well as patients to choose DBS over drug therapy since drug therapy is known to have several side effects and its efficacy cannot be accurately gauged. The Parkinson’s Disease Foundation (PDF) estimates that nearly 10 million people worldwide suffer from this disorder, with one million of these living in America alone.

DBS surgical therapy is the therapy of choice in the advanced stages of Parkinson’s disease, whereas medical practitioners typically recommend chemotherapy in the early stages. The report discusses the aspects and considerations that make DBS devices a preferred option as compared to other treatment methods such as stem cell therapy, drug therapy, and physical therapy.

This market research report by Transparency Market Research also goes on to discuss the geographical segmentation of the deep brain stimulation devices market. The market is broadly segmented as North America, Asia-Pacific, Europe and Latin America. Users can expect to gain deep insights into the market potential and growth projections for each of these markets. It also talks about factors that will promote or restrain growth in these markets.